Literature DB >> 28829255

Field Trials of Genetically Modified Mosquitoes and Public Health Ethics.

David B Resnik1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28829255      PMCID： PMC6072261          DOI： 10.1080/15265161.2017.1353170

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN： 1526-5161            Impact factor:   11.229


× No keyword cloud information.
  7 in total

1.  Ethical, legal and social issues of genetically modifying insect vectors for public health.

Authors:  Darryl Macer
Journal:  Insect Biochem Mol Biol       Date:  2005-03-28       Impact factor: 4.714

2.  Winged warriors.

Authors:  Kelly Servick
Journal:  Science       Date:  2016-10-14       Impact factor: 47.728

3.  Ethics of community engagement in field trials of genetically modified mosquitoes.

Authors:  David B Resnik
Journal:  Dev World Bioeth       Date:  2017-05-03       Impact factor: 2.294

Review 4.  A Bridge Back to the Future: Public Health Ethics, Bioethics, and Environmental Ethics.

Authors:  Lisa M Lee
Journal:  Am J Bioeth       Date:  2017-09       Impact factor: 11.229

5.  Ethical issues in field trials of genetically modified disease-resistant mosquitoes.

Authors:  David B Resnik
Journal:  Dev World Bioeth       Date:  2012-12-21       Impact factor: 2.294

6.  Human health and the environment: in harmony or in conflict?

Authors:  David B Resnik
Journal:  Health Care Anal       Date:  2009-01-07

7.  Suppression of a Field Population of Aedes aegypti in Brazil by Sustained Release of Transgenic Male Mosquitoes.

Authors:  Danilo O Carvalho; Andrew R McKemey; Luiza Garziera; Renaud Lacroix; Christl A Donnelly; Luke Alphey; Aldo Malavasi; Margareth L Capurro
Journal:  PLoS Negl Trop Dis       Date:  2015-07-02
  7 in total
  1 in total

1.  Coupled small molecules target RNA interference and JAK/STAT signaling to reduce Zika virus infection in Aedes aegypti.

Authors:  Chasity E Trammell; Gabriela Ramirez; Irma Sanchez-Vargas; Laura A St Clair; Oshani C Ratnayake; Shirley Luckhart; Rushika Perera; Alan G Goodman
Journal:  PLoS Pathog       Date:  2022-04-04       Impact factor: 7.464
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.